Moreover, ustekinumab treatment significantly increased mRNA expression of CREB3L1 gene encoding a transcription factor involved in bone formation (43); CREB3L1 deficiency can cause severe osteogenesis imperfecta (44). Here, CREB3L1 is linked to osteogenesis imperfecta.